← Eichor
Study identifier: NCT06788821 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prenatal Ultrasonographic Assessment of Fetal Thyroid in Patients With Thyroid Pathology

Condition: Thyroid Disease Pregnancy  ·  Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

PhaseN/A
Planned participants440
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersNo

About this study

The goal of this observational study is to evaluate the possibility to use prenatal ultrasonography for diagnosis and prognostic guidance in cases of suspected fetal thyroid changes in fetuses belonging to women with thyroid disease and women with low obstetric risk (i.e., pregnancy not complicated by maternal and/or fetal pathology) between 14 and 37 gestational weeks. The main question it aims to answer is: Is it possible to diagnose thyroid disease in fetuses early using measurable parameters of the fetal thyroid through ultrasonography?

This description comes directly from the study's public registry record.

Talk to the study team

Elena Contro, MD  ·  0512143705  ·  elena.contro@aosp.bo.it

Always discuss trial participation with your own doctor first.

Locations (2)

IRCCS Azienda Ospedaliero-Universitaria di BolognaBologna, Bologna, ItalyRecruiting
Ospedale Santa Chiara - TrentoTrento, Italy, ItalyNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06788821